1. Home
  2. BKH vs ADMA Comparison

BKH vs ADMA Comparison

Compare BKH & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Black Hills Corporation

BKH

Black Hills Corporation

HOLD

Current Price

$72.74

Market Cap

5.4B

Sector

Utilities

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$17.38

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BKH
ADMA
Founded
1941
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
4.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BKH
ADMA
Price
$72.74
$17.38
Analyst Decision
Buy
Strong Buy
Analyst Count
3
2
Target Price
$71.00
$28.50
AVG Volume (30 Days)
740.6K
2.1M
Earning Date
02-04-2026
03-02-2026
Dividend Yield
3.69%
N/A
EPS Growth
7.21
205.35
EPS
3.95
0.86
Revenue
$2,271,600,000.00
$488,559,000.00
Revenue This Year
$10.35
$22.13
Revenue Next Year
$3.07
$24.15
P/E Ratio
$18.56
$20.28
Revenue Growth
7.04
27.63
52 Week Low
$54.92
$13.50
52 Week High
$74.02
$25.67

Technical Indicators

Market Signals
Indicator
BKH
ADMA
Relative Strength Index (RSI) 60.76 40.70
Support Level $71.76 $16.62
Resistance Level $73.78 $18.34
Average True Range (ATR) 1.65 0.82
MACD 0.26 -0.13
Stochastic Oscillator 83.10 42.44

Price Performance

Historical Comparison
BKH
ADMA

About BKH Black Hills Corporation

Black Hills Corp is a U.S.-based energy company that operates through its Electric Utilities and Gas Utilities segment. These segments operate in states in the Midwest and mountain regions in the U.S. The company's customers include residential, commercial, industrial, and municipal consumers. These customers are residential. Black Hills derives the majority of its revenue from its utility business group, specifically from gas utilities.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Share on Social Networks: